Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 155,464 | 189,182 | 226,748 | 523,506 | 123,406 |
| Marketable Securities | 294,420 | 412,333 | 685,475 | 669,116 | 625,282 |
| Receivables | 9,468 | 8,517 | 36,456 | 3,768 | 2,031 |
| TOTAL | $527,711 | $639,863 | $998,330 | $1,216,797 | $769,303 |
| Non-Current Assets | |||||
| PPE Net | 17,671 | 27,381 | 32,760 | 27,921 | 20,968 |
| Investments And Advances | 155,250 | 260,215 | 111,629 | 101,793 | 395,492 |
| Other Non-Current Assets | 141,495 | 263,556 | 158,258 | 173,603 | 108,701 |
| TOTAL | $314,416 | $551,152 | $302,647 | $303,317 | $525,161 |
| Total Assets | $842,127 | $1,191,015 | $1,300,977 | $1,520,114 | $1,294,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,252 | 14,589 | 7,452 | 5,154 | 9,653 |
| Accrued Expenses | 49,862 | 55,355 | 67,017 | 60,876 | 43,309 |
| TOTAL | $103,884 | $110,851 | $115,208 | $126,554 | $125,833 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,290 | 20,661 | 22,140 | 43,839 | 63,759 |
| Other Non-Current Liabilities | 66,849 | 189,952 | 96,747 | 138,044 | 64,911 |
| TOTAL | $66,849 | $208,208 | $135,600 | $157,976 | $128,387 |
| Total Liabilities | $170,733 | $319,059 | $250,808 | $284,530 | $254,220 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,134 | 103,518 | 96,106 | 88,018 | 74,672 |
| Common Shares | 12 | 10 | 9 | 9 | 7 |
| Retained earnings | -2,590,094 | -2,177,400 | -1,658,379 | -1,177,187 | -703,001 |
| Other shareholders' equity | 1,032 | 605 | -2,258 | -7,461 | -2,632 |
| TOTAL | $671,394 | $871,956 | $1,050,169 | $1,235,584 | $1,040,244 |
| Total Liabilities And Equity | $842,127 | $1,191,015 | $1,300,977 | $1,520,114 | $1,294,464 |